Cargando…
Beyond Expectations: A Case of Doxorubicin-Induced Cardiomyopathy at a Remarkably Low Cumulative Dose
Anthracycline and its associated cardiotoxicity have been well-established in the literature. With decades of use of anthracycline for a variety of cancer treatments and increased cancer survivability, a detailed study on its cardiac effects is in the continuum. Higher doses of anthracyclines were p...
Autores principales: | Shrestha, Nisij, Rajbhandari, Prasun, Mandal, Sujit Kumar, Janjua, Sarosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439838/ https://www.ncbi.nlm.nih.gov/pubmed/37605690 http://dx.doi.org/10.7759/cureus.42217 |
Ejemplares similares
-
Potential Therapeutic Treatments for Doxorubicin-Induced Cardiomyopathy
por: Kabir, Shadman, et al.
Publicado: (2022) -
Takotsubo Cardiomyopathy Following COVID-19 Vaccine Booster Dose: A Case Report
por: Reza, Rezaur Rahman, et al.
Publicado: (2023) -
Cardiac Safety of Pegylated Liposomal Doxorubicin After Conventional Doxorubicin Exposure in Patients With Sarcoma and Breast Cancer
por: Alhaja, Maher, et al.
Publicado: (2023) -
Takotsubo Cardiomyopathy in a Patient with Preexisting Hypertrophic Cardiomyopathy
por: Elhosseiny, Sherif, et al.
Publicado: (2018) -
Unique Case of Cardiogenic Shock in the Setting of Cumulative Calcium Channel Blocker Toxicity
por: Afzal, Muhammad A, et al.
Publicado: (2023)